Teva

Teva holding off launch of opioid addiction drug

https://pharmaphorum.com/news/teva-holding-off-launch-of-opioid-addiction-drug/

Regeneron/Teva pain drug fasinumab on target in phase 3

https://pharmaphorum.com/news/regeneron-teva-pain-drug-fasinumab-target-phase-3/

Concerns over Teva migraine drug because of manufacturing issues

https://pharmaphorum.com/news/concerns-over-teva-migraine-drug-because-of-manufacturing-issues/

Remote HCP engagement – still a struggle for life science companies

https://pharmaphorum.com/white-papers/remote-hcps-engagement-life-science/

Novartis/Amgen migraine jab works in tough-to-treat patients

https://pharmaphorum.com/news/novartis-amgen-migraine-jab-works-tough-treat-patients/

FDA rejects Teva/Celltrion biosimilars

https://pharmaphorum.com/news/fda-rejects-teva-celltrion-biosimilars/

Sosei see Teva pipeline cull as an opportunity

https://pharmaphorum.com/news/sosei-loses-teva-culls-migraine-pipeline/

Ex-Teva exec to be new Hikma CEO

https://pharmaphorum.com/transversal-categories/uk-and-europe/ex-teva-exec-new-hikma-ceo/

Novartis/Amgen migraine drug reduces attacks after others fail

https://pharmaphorum.com/news/novartisamgen-migraine-drug-reduces-attacks-others-fail/

«< 3 4 5 6 7 >»

Close in 10 seconds

Pharmaphorum.com

Search